Announcements
- Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
- Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
- Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
- Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
- Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
- Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
- Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
- Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
- Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
More ▼
Key statistics
On Wednesday, Adaptive Biotechnologies Corp (1HM:FRA) closed at 3.81, 77.19% above the 52 week low of 2.15 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.81 |
---|---|
High | 3.81 |
Low | 3.81 |
Bid | 3.80 |
Offer | 3.89 |
Previous close | 3.76 |
Average volume | 408.22 |
---|---|
Shares outstanding | 147.37m |
Free float | 144.42m |
P/E (TTM) | -- |
Market cap | 618.95m USD |
EPS (TTM) | -1.48 USD |
Data delayed at least 15 minutes, as of Jul 24 2024 07:02 BST.
More ▼